NCT06053658 2026-04-14
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center
Phase 2 Recruiting
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Alliance for Clinical Trials in Oncology